University of Kentucky

UKnowledge
Center of Excellence in Rural Health Faculty
Publications

Rural Health

9-19-2014

Dimethyl Sulfoxide Damages Mitochondrial Integrity and
Membrane Potential in Cultured Astrocytes
Chan Yuan
Nanjing Medical University, China

Junying Gao
Nanjing Medical University, China

Jichao Guo
Nanjing Medical University, China

Lei Bai
Nanjing Medical University, China

Charles Marshall
University of Kentucky, charles.marshall@uky.edu

See next page for additional authors
Follow this and additional works at: https://uknowledge.uky.edu/ruralhealth_facpub
Part of the Medicine and Health Sciences Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Yuan, Chan; Gao, Junying; Guo, Jichao; Bai, Lei; Marshall, Charles; Cai, Zhiyou; Wang, Linmei; and Xiao,
Ming, "Dimethyl Sulfoxide Damages Mitochondrial Integrity and Membrane Potential in Cultured
Astrocytes" (2014). Center of Excellence in Rural Health Faculty Publications. 5.
https://uknowledge.uky.edu/ruralhealth_facpub/5

This Article is brought to you for free and open access by the Rural Health at UKnowledge. It has been accepted for
inclusion in Center of Excellence in Rural Health Faculty Publications by an authorized administrator of
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

Dimethyl Sulfoxide Damages Mitochondrial Integrity and Membrane Potential in
Cultured Astrocytes
Digital Object Identifier (DOI)
http://dx.doi.org/10.1371/journal.pone.0107447

Notes/Citation Information
Published in PLOS One, v. 9, no. 9, article e107447, p. 1-9.
© 2014 Yuan et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author
and source are credited.

Authors
Chan Yuan, Junying Gao, Jichao Guo, Lei Bai, Charles Marshall, Zhiyou Cai, Linmei Wang, and Ming Xiao

This article is available at UKnowledge: https://uknowledge.uky.edu/ruralhealth_facpub/5
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Abstract
Dimethyl sulfoxide (DMSO) is a polar organic solvent that is used to dissolve neuroprotective or neurotoxic agents in
neuroscience research. However, DMSO itself also has pharmacological and pathological effects on the nervous system.
Astrocytes play a central role in maintaining brain homeostasis, but the effect and mechanism of DMSO on astrocytes has
not been studied. The present study showed that exposure of astrocyte cultures to 1% DMSO for 24 h did not significantly
affect cell survival, but decreased cell viability and glial glutamate transporter expression, and caused mitochondrial
swelling, membrane potential impairment and reactive oxygen species production, and subsequent cytochrome c release
and caspase-3 activation. DMSO at concentrations of 5% significantly inhibited cell variability and promoted apoptosis of
astrocytes, accompanied with more severe mitochondrial damage. These results suggest that mitochondrial impairment is a
primary event in DMSO-induced astrocyte toxicity. The potential cytotoxic effects on astrocytes need to be carefully
considered during investigating neuroprotective or neurotoxic effects of hydrophobic agents dissolved by DMSO.
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toxicity. Therefore, it is necessary to further explore the
neuropharmacological and neurotoxicological effects of DMSO.
Astrocytes, the most numerous glial cells in the mammalian
brain, are responsible for maintaining brain homeostasis [23]. For
example, astrocytes regulate glutamatergic neurotransmission and
prevent glutamate excitotoxicity by removing excess glutamate
from the extracellular synaptic space through glutamate transporters [24]. Astrocyte dysfunction has been implicated in a
variety of neurological diseases [25]. Based on this, it is necessary
to investigate effects of DMSO on astrocytes. However, to our
knowledge, this issue has not been explored.
In the present study we provided evidence that DMSO has
cytotoxic effects on astrocytes via disruption of mitochondrial
integrity and membrane potential, resulting in oxidative stress,
apoptosis and down-regulation of glutamate transporters. This
finding expands our understanding of the neurotoxic mechanisms
of DMSO and provides an experimental basis to select a safe dose
of DMSO in neuroscience research.

Introduction
Dimethyl sulfoxide (DMSO) is a polar organic solvent with
various biological functions that is used extensively in both
biological and medical research [1,2]. In the neuroscience field,
DMSO is commonly used to dissolve hydrophobic neuroprotective
or neurotoxic agents [3]. Studies have also investigated the
potential effects of DMSO itself on the nervous system [4–8].
DMSO treatment has been shown to reduce infarction volume
and neuronal loss in rodent cerebral ischemia models [9–11].
Nevertheless, it has been demonstrated that DMSO produces
widespread neuronal apoptosis in the developing mouse brain and
neuronal loss in rat hippocampal culture [12]. DMSO also can
induce tau hyperphosphorylation, a hallmark of Alzheimer’s
disease, in the adult mouse brain [13]. DMSO produces a dosedependent reduction in nerve conduction velocity with myelin
disruption of the rat sciatic nerve [4]. These discrepant data
suggest that DMSO plays protective or injurious roles in the brain,
which may be due to differences in the model used as well as the
concentration of DMSO administered.
Furthermore, there are several case reports that reveal severe
neurotoxicity [14–18], encephalopathy [19–21] and transient
global amnesia [22] associated with the infusion of DMSOcryopreserved hematopoietic stem/progenitor cells. These results
highly suggest that DMSO has neurological side effects and
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Results
DMSO decreased survival and viability of cultured
astrocytes
DMSO at concentrations of 0.5–1.5% is widely used as a
solvent for various pharmacological agents in neuroscience
research [3]. Thus, we selected DMSO at concentrations of 1%
1
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and 5% to observe and compare their neurotoxic profile in
cultured astrocytes during a 24-h exposure period. Exposure of
cultures to 1% DMSO had no significant effect on the growth and
survival of astrocytes, but the cell viability was decreased by 16%,
as revealed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. DMSO at concentrations of 5%
caused a 40% decrease in the cell density and a 32% decrease in
the cell viability (Figure 1A–C).

DMSO caused mitochondrial cytochrome c (Cyt c) release
in cultured astrocytes
It is also known that disruption of mitochondrial integrity results
in a release of Cyt c from the mitochondrial intermembrane space
into the cytosol [30]. Therefore, we investigated the effects of
DMSO on mitochondrial Cyt c release in cultured astrocytes. The
flow cytometry results showed that the concentration of Cyt c in
the astrocyte cytoplasm increased after treatment with 1% and 5%
DMSO for 24 h (Figure 4A–B). The Western blotting further
confirmed that DMSO induced Cyt c release from the mitochondria. DMSO-treated astrocytes had low levels of Cyt c in the
mitochondrial fraction and high levels of Cyt c in the cytosolic
fraction, compared with intact controls (Figure 4C–D).

DMSO impaired mitochondrial integrity and membrane
potential of cultured astrocytes
DMSO has been shown to concentration-dependently modulate
the structure and properties of cell membranes [26,27]. The
mitochondrial membrane has a typical lipid bilayer structure and
is vulnerable to various injury factors [28]. It is also known that
mitochondrial damage is a major cause of decreased cell viability
[29]. Thus, the impairment of DMSO on astrocyte mitochondria
was investigated by using the transmission electron microscopy.
Astrocytes treated with 1% DMSO for 24 h showed swelling of
mitochondria (Figure 2A), as revealed by quantitation of mitochondrial cross-sectional area (Figure 2B). The swelling and
disruption of mitochondria were more evident after exposure to
5% DMSO, and about 35% of mitochondria exhibited loss of
cristae or formed monolayer vacuoles (Figure 2C).
The deleterious effect of DMSO on mitochondrial function of
astrocytes was also determined by measurement of mitochondrial
membrane potential (DYm) using fluroescence microscopy of
tetramethylrhodamine methyl (TMRE). DMSO at concentrations
in 1% and 5% caused significant decreases in DYm in cultured
astrocytes, as shown in Figure 3A and B.

DMSO increased reactive oxygen species (ROS)
generation in cultured astrocytes
It has been demonstrated that decreased DYm reduces aerobic
metabolism and increases ROS generation [31,32]. Thus, the
generation of mitochondrial ROS in DMSO-treated astrocytes
was assessed by detection of MitoSOX-Red, a highly selective
detector of superoxide in live cell mitochondria, using the flow
cytometry. The intensity of Mito-SOX fluorescence was increased
in a concentration dependent manner (Figure 5A–B). DMSOincreased intracellular ROS levels were also observed using an
oxidant-sensitive probe DCFH-DA and the flow cytometry
(Figure 5C–D).

Figure 1. Effects of DMSO on survival and viability of mouse cortical astrocytes in culture. (A) General growth profile of incubated with
various concentrations of DMSO for 24 h. Astrocytes were grown well and closely adhered to each other on the surface of coverslips under normal
circumstances and exposed to 1% DMSO. Many astrocytes were detached from the coverslips in 5% DMSO culture medium. (B–C) Quantitative
analysis of the cell density (B) and cell viability (C) of astrocytes incubated with different concentrations of DMSO for 24 h. Data are shown as a mean
6 SEM of five independent experiments performed in triplicate. *P,0.05 and **P ,0.01 versus control group.
doi:10.1371/journal.pone.0107447.g001
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Figure 2. Effects of DMSO on substructures of cultured mouse cortical astrocytes. (A) Representative transmission electron micrographs
showing substructural morphology of astrocytes after treatment with different concentrations of DMSO for 24 h. The disruption of mitochondria
integrity becomes more severe with increased DMSO concentrations. Fragmentation of the nucleus, with condensation and margination of nuclear
chromatin, was frequently observed in astrocytes exposed to 5% DMSO. (B) Quantitation of mitochondrial cross-sectional area. The results confirmed
DMSO-induced mitochondrial swelling, with a significant rightward shift in the mitochondrial area cumulative frequency curve, relative to untreated
control. (C) The quantitative analysis showed increases in the percentage of mitochondrial vacuolization in astrocytes treated with DMSO in a dosedependent manner. Data are shown as a mean 6 SEM of five independent experiments. *P,0.05 and **P,0.01 versus control group.
doi:10.1371/journal.pone.0107447.g002

apoptotic protein Bcl-2 expression and procaspse-3 expression,
while increases in cleaved caspase-3 expression, as revealed by the
Western blot analysis (Figure 6C–D).

DMSO induced apoptosis of cultured astrocytes
There is evidence that Cyt c release and ROS generation caused
by mitochondria damage and/or dysfunction play a central role in
initiating apoptosis [33–36]. Thus, we examined the effects of
DMSO on astrocyte apoptosis. The terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) and quantitative
analysis revealed that the percentage of apoptotic astrocytes was
not significantly different between the baseline condition and 1%
DMSO, but increased in 5% DMSO (Figure 6A–B). Astrocytes
exposed to 1% or 5% DMSO for 24 h showed decreases in antiPLOS ONE | www.plosone.org

DMSO decreased glutamate transporter 1 (GLT-1) and
glutamate-aspartate transporter (GLAST) expression in
cultured astrocytes
Astrocytes are responsible for maintaining glutamate homeostasis in the central nervous system by glutamate transporters that
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that DMSO modulates the structure and properties of cell
membranes in a concentration-dependent manner [27]. DMSO
induces membrane thinning and increases fluidity of the membrane’s hydrophobic core at low concentrations (,10 mol%),
formation of transient water pores in the bilayer membrane at 10–
20 mol%, and local loss in integrity of the phospholipid
membranes at higher concentrations. The present results demonstrated that cultured mouse astrocytes exposed to 1.0% DMSO for
24 h exhibit impairments of the mitochondrial integrity and DYm,
although their general growth profile is not altered compared to
those in control medium. This result suggests that mitochondrial
membrane is vulnerable to DMSO, which might be due to its
relatively high membrane fluidity [28].
Mitochondria are the center of cell metabolism and energy
transformation; and their malfunction decreases cell viability
[29,41]. In agreement with this notion, we demonstrated that
DMSO inhibits astrocyte viability in a dose-dependent manner,
accompanied with mitochondrial structural and functional disruption. Astrocytes exposed to DMSO at concentrations of 1.0%
also increases Cyt c release and activated caspase 3 expression, and
decreases anti-apoptotic protein Bcl-2 expression, supporting the
review that rupture of mitochondria is an initial trigger of
apoptotic cascades [28,35]. Furthermore, the present results
indicated that DMSO dose-dependently increases mitochondriaderived ROS production, which is consistent with the notion that
degenerated mitochondria are the primary site of ROS production
[32]. Taken together, these results reveal that mitochondrial
impairment is a primary event in the astrocyte toxicity of DMSO.
Glutamate, the major excitatory amino acid neurotransmitter in
the brain, can become potentially toxic when it over-accumulates
in the synaptic space [42]. As mentioned earlier, astrocytes are
responsible for maintaining brain glutamate homeostasis via
glutamate transporters [24]. Oxidative stress inhibits glutamate
transporter expression and function, which has been implicated as
a main pathogenesis for glutamate excitotoxicity in a variety of
pathological conditions, including brain ischemia [43,44], traumatic brain injury [45], epilepsy [46] and neurodegeneration
[47,48]. The present results have demonstrated that DMSO
causes down-regulation of GLT1 and GLAST in cultured
astrocytes. In addition to increased ROS production, decreased
cell viability and mitochondrial dysfunction may impair glutamate
transporter synthesis by astrocytes. High concentration of DMSO
has been shown to degrade membrane structure and disturb
secondary protein structures within membrane proteins [26,27].
This may also contribute to decreased expression of GTL1 and
GLAST. Down-regulation of glutamate transporters may lead to
neuronal excitotoxicity, thus exacerbating DMSO-induced neuronal damage. The results help to explain the occurrence of
epilepsy in humans [14–18] and rats [49] following exposure to
high concentration of DMSO.
In summary, the present results reveal that mitochondrial
damage, oxidative stress and apoptosis are involved in DMSOinduced astrocyte toxicity. DMSO at concentrations of 1%
impairs cell viability, mitochondrial integrity and glutamate
transporter expression of astrocytes, although does not affect their
survival and apoptosis during a 24-h exposure period. Further in
vivo studies are necessary to address whether astrocyte dysfunction
is involved in neurobehavioral consequences of acute high dose or
chronic low dose exposure to DMSO. Exploring these issues will
help objective evaluation of pharmacological or toxicological
effects of DMSO itself, or as a solvent or carrier for hydrophobic
agents.

Figure 3. Effects of DMSO on DYm of cultured mouse cortical
astrocytes. (A) Representative micrographs showing DYm, revealed
by TMRE fluorescent staining, in astrocytes treated with various
concentrations of DMSO for 24 h. The left first micrograph is a positive
control for depolarized mitochondria by incubated with 20 mM FCCP,
an uncoupler of electron transport and oxidative phosphorylation, for
10 minutes prior to staining with TMRE. (B) The quantitative analysis
revealed that TMRE fluorescence intensity was decreased in astrocytes
treated with DMSO in a dose-dependent manner. Data are shown as a
mean 6 SEM of five independent experiments performed in triplicate.
*P,0.05 and **P,0.01 versus control group.
doi:10.1371/journal.pone.0107447.g003

are vulnerable to oxidative stress [37]. Thus, we examined
whether increased ROS generation resulted in down-regulation of
GLT-1 and GLAST in DMSO-treated astrocytes. The immunoreactivity for these proteins decreased in astrocytes exposed to 1%
and 5% DMSO (Figure 7A–B). DMSO-reduced GLT-1 and
GLAST expression in a concentration-dependent pattern was
confirmed by the Western blot analysis (Figure 7C–D).

Discussion
DMSO at concentrations of 0.5–1.5% is widely used as a
solvent for various pharmacological agents in both cell culture and
in vivo studies [3]. However, the biological effects of DMSO may
be neglected, because a vehicle control is not always incorporated
into the design of experiments. An early study suggested that
exposure of primary hippocampal cell cultures to DMSO in the
range of 0.5–1.0% for 24 h has no significant effect on the survival
of neurons, but can prevent glutamate-induced neuronal death via
suppression of NMDA- and AMPA-induced ion currents and
calcium influx [38]. A followed study has shown that treatment
with DMSO at concentrations of 0.5% or 1.0% for 6 DIV
produces a substantial decrease in the number of cultured
hippocampal neurons [12]. In the present study, a DMSO
concentration of 1% does not significantly affect the astrocyte
survival during a 24-h exposure period, but impairs cell viability,
mitochondrial integrity and glutamate transporter expression.
Exposure of astrocyte cultures to DMSO at concentrations of 5%
significantly impairs cell survival and increased apoptosis. Collectively, these results provide strong in vitro evidence for the
neuropharmacological and neurotoxicological effects of DMSO.
The amphiphilic characteristic of DMSO imparts extensive
actions in membrane fusion processes, cryopreservation, and
membrane permeability enhancement [39,40]. A molecular
dynamics simulation employing coarse-grained models suggested

PLOS ONE | www.plosone.org
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Figure 4. Effects of DMSO on and the release of mitochondrial Cyt c and intracellular ROS generation in cultured mouse cortical
astrocytes. (A) Representative flow cytometry data showing mitochondrial Cyt c-FITC fluorescence within the cytoplasm of astrocytes treated with
various concentrations of DMSO for 24 h. (B) Quantitative analysis of Cyt c-FITC fluorescence intensity. (C) Representative western blot bands showing
expression levels of Cyt c in cytosolic and mitochondrial fractions of astrocytes treated with various concentrations of DMSO for 24 h. b-tubulin and
COX IV, which were exclusively expressed within the cytosol and mitochondria, respectively, were used as loading controls. (D) The quantitative
analysis of the relative optical density of cytosol and mitochondrial Cyt c showing that DMSO caused translocation of Cyt c from the mitochondria
into the cytoplasm of astrocytes. Data are shown as a mean 6 SEM of five (for flow cytometry) or four (for Western blot) independent experiments
performed in triplicate. *P,0.05 and **P,0.01 versus control group.
doi:10.1371/journal.pone.0107447.g004

Adult CD1 mice (8–10-weeks-old) weighting 20–25 g were
housed 4 per cage in a room maintained at 2261uC with an
alternating 12 h light–dark cycle. Food and water was available ad
libitum. Animal protocols used in the study were approved by the
Institutional Animal Care and Use Committee (IACUC) of
Nanjing Medical University.

Astrocytes of the second passage were then resuspended in
DMEM/10% FBS, and plated into poly-L-lysine-coated plates as
follows: 24-well microtiter plates (56105 cells/well) for morphological, immunocytochemical, DYm and apoptosis assays, 96-well
microtiter plates (26104 cells/well) for viability assay, and 6-well
plates (26106 cells/well) for Western blot and flow cytometric
analyses. The cells were allowed to grow for 1–2 days to reach
confluence, then treated with different concentrations (0, 1 and
5%) of DMSO (Sigma-Aldrich, St. Louis, MO, USA) for 24 h.

Astrocyte cultures and drug treatment

Astrocyte survival and morphological assay

The cerebral cortices of post-natal day 1–3 CD1 mice were
isolated and dissociated with 0.125% trypsin (Millipore, Billerica,
MA, USA) digestion and trituration with a flame-polished pasture
pipet. Following filtration, dissociated cells were suspended in
Dulbecco’s modified Eagle’s medium (DMEM) plus 10% fetal
bovine serum (FBS) (Gibco BRL, Guithersburg, MD, USA), then
plated into tissue culture flasks coated with 100 mg/ml poly-Llysine (Sigma-Aldrich, St. Louis, MO, USA), and placed in a
humidified cell culture incubator at 37uC in an atmosphere of
95% air and 5% CO2. Culture medium was changed every 2 or 3
days. Seven or eight days after plating, cells were passaged,
subjected to a partial media exchange, and incubated for another
5–6 days. The cultures consisted of at least 95% astrocytes as
determined by immunostaining against the astrocyte marker glial
fibrillary acidic protein (GFAP) and the microglial marker CD11b.

After treatment with different concentrations of DMSO for
24 h, the growth of astrocytes was examined by a phase contrast
microscope and 5 randomly selected areas per well were imaged at
1006magnification. Total number of cells in each image was
counted using the Image J software (National Institutes of Health,
Bethesda, MD, USA). The density of cells (cell number per mm2)
was calculated and expressed as a percentage of the untreated
control cells.

Experimental Methods
Animals

PLOS ONE | www.plosone.org

Cell viability assay
Cell viability was evaluated by MTT assay [50]. After
replacement of fresh DMEM, 20 ml of 5 mg/ml MTT (SigmaAldrich) was added and incubated for 4 h, the culture medium was
discarded and 150 ml DMSO was used to dissolve the precipitate.
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Figure 5. Effects of DMSO on mitochondrial and intracellular ROS generation in cultured mouse cortical astrocytes. (A)
Representative flow cytometry data showing Mito-SOX fluorescence, a highly selective indicator of superoxide in live cell mitochondria, in astrocytes
treated with various concentrations of DMSO for 24 h. (B) Quantitative analysis revealed that the Mito-SOX fluorescence intensity increased in
astrocytes treated with DMSO with a dose-dependent manner. (C) Representative flow cytometry data showing DCF fluorescence in astrocytes
treated with various concentrations of DMSO for 24 h. (D) The quantitative analysis showed that ROS levels were increased in astrocytes treated with
DMSO at 5% concentration but not at 1%, by detecting the fluorescence intensity of DCF. (E) Data are shown as a mean 6 SEM of five independent
experiments performed in triplicate. *P,0.05, **P,0.01 versus control group. #P,0.05, ## P,0.01 versus 5% DMSO treated group.
doi:10.1371/journal.pone.0107447.g005

Figure 6. Effects of DMSO on apoptosis of cultured mouse cortical astrocytes. Astrocytes were incubated with various concentrations of
DMSO for 24 h. (A) Representative micrographs showing TUNEL positive apoptotic astrocytes (cyan-blue). Cell nuclei counterstained with Hoechst
33342 (blue). (B) Quantitative analysis of astrocyte apoptosis. (C) Representative western blot bands showing expression levels of procaspase-3,
cleaved caspase-3 and Bcl-2 in astrocytes. (D) The quantitative analysis showed that Bcl-2 and procaspase-3 expression levels were decreased, but
cleaved caspase-3 expression level was increased in astrocytes treated with 1% or 5% DMSO. Data are shown as a mean 6 SEM of five (for TUNEL) or
four (for Western blot) independent experiments performed in triplicate. *P,0.05 and **P,0.01 versus control group.
doi:10.1371/journal.pone.0107447.g006

PLOS ONE | www.plosone.org
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Figure 7. Effects of DMSO on expression of GLT-1 and GLAST in cultured mouse cortical astrocytes. (A) Representative micrographs
showing immunoreactivity of GLT-1 and GLAST in astrocytes treated with various concentrations of DMSO for 24 h. (B) Mean integrated optical
density (MIOD) of immunostaining for GLT-1 and GLAST. (C) Representative western blot bands showing expression levels of GLT-1 and GLAST in
astrocytes. (D) Quantitative analysis revealed that GLT-1 and GLAST protein levels were decreased in astrocytes treated with DMSO in a dosedependent manner. Data are shown as a mean 6 SEM of five (for immunostaining) or four (for Western blot) independent experiments performed in
triplicate. *P,0.05 and **P,0.01 versus control group.
doi:10.1371/journal.pone.0107447.g007

The absorbance was measured at 490 nm using an Automated
Microplated Reader ELx800 (BioTek, Winooski, VT, USA).
Results are expressed as percentage of control values.

oxidative phosphorylation, for 10 minutes prior to staining with
TMRE, served as a positive control for depolarized mitochondria.
The TMRE fluorescence density was analyzed using an Image-Pro
Plus 6.0 Analysis System. The data are presented as percentage of
control values.

Transmission electron microscopy
DMSO-treated astrocytes were fixed with 4uC 2.5% glutaraldehyde in phosphate buffer saline (PBS, pH 7.4) for 2 h. The cells
were detached with 0.125% trypsin, and collected by centrifugation for 10 min at 1000 g, rinsed with PBS and post-fixed in 1%
osmium tetroxide with 0.1% potassium ferricyanide for 48 h. The
cell samples were dehydrated through a graded series of ethanol,
and embedded in Epon 812. Sixty-micrometer-thick ultrasections
were stained with 1% uranyl acetate and 0.1% lead citrate, and
examined with a Jeol 1200EX electron microscope (Jeol Ltd.,
Akishima, Tokyo, Japan). Ten astrocytes from each group were
randomly captured at a magnification of 612000 and used for
quantitation of mitochondrial cross-sectional area using an ImagePro Plus 6.0 Analysis System (Media Cybernetics Inc., San
Francisco, CA, USA). The percentage of vacuolated mitochondria, characterized by partial or complete loss of cristae, was
counted.

Assay of Cyt c release
After treatment with different concentrations of DMSO for
24 h, cultured astrocytes were incubated in 4uC permeabilisation
buffer (100 mM KCl, 100 mg/ml digitonin in PBS) for 3–5 min.
The cells were fixed with 4% paraformaldehyde in PBS for 20 min
at room temperature, washed twice with PBS, and detached
enzymatically. The cells were then centrifuged, resuspended in
1 ml blocking buffer (3% bovine serum albumin, 0.05% saponin in
PBS) for 1 h at room temperature, and incubated with mouse
monoclonal anti-Cyt c (1:2000; Abcam, San Francisco, CA, USA)
overnight at 4uC. The cells were rinsed twice with PBS, then
incubated with FITC conjugate secondary antibody (1:200, Vector
Laboratories, Burlingame, CA, USA) for 1 h at the room
temperature. The samples were analyzed by a FACSCalibur flow
cytometer (Becton-Dickinson) at an excitation wavelength of
488 nm and an emission wavelength of 525 nm.

Measurement of DYm
DYm was assessed using a live cell assay with the fluorescent
lipophilic cationic dye TMRE (Invitrogen, Karlsruhe, Germany).
This dye is a cell permeant, positively-charged, red-orange dye
that readily accumulates in active mitochondria due to their
relative negative charge [51]. After treatment with different
concentrations of DMSO for 24 h, cultured astrocytes were
stained with 200 nM TMRE for 30 min at 37uC, then washed
twice in medium and re-suspended in PBS. The fluorescent images
were immediately taken using a Zeiss AX10 inverted fluorescence
scope (Carl Zeiss Microimaging Inc., Germany). Some samples
incubated with 20 mM carbonylcyanide-p-trifluoromethoxyphenylhydrazone (FCCP), an uncoupler of electron transport and
PLOS ONE | www.plosone.org

Measurement of mitochondrial and intracellular ROS
generation
Mitochondria-mediated ROS generation was detected with the
mitochondrial superoxide indicator MitoSOX-Red. Intracellular
ROS were detected using an oxidation-sensitive fluorescent probe
29-79-dichlorodihydrofluorescein diacetate (DCFH-DA). DCFHDA was deacetylated intracellularly by nonspecific esterase, which
was then further oxidized by ROS to the fluorescent compound
2,7-dichlorofluorescein (DCF) [52]. Astrocytes were treated with
different concentrations of DMSO (0, 1 and 5%). Cells were then
washed twice in PBS and placed in a humidified incubator (5%
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ries), rinsed and visualized by ECL plus Western blotting detection
system. b-tubulin was used as an internal control.

CO2 and 95% air) at 37uC with 5 mmol/L of MitoSOX-Red
(Invitrogen) for 15 min or 2.5 mg/ml DCFH-DA (Sigma-Aldrich)
in PBS for 30 min. Subsequently, the cells were washed twice in
culture medium and trypsinized. The cell pellet was re-suspended
in PBS followed by analysis on a FACSCalibur flow cytometer
(Becton-Dickinson).

Apoptosis assay
Cell apoptosis was detected by TUNEL assay using the In Situ
Cell Death Detection Kit (Roche Diagnostics GmbH, Mannheim,
Germany). After treatment with different concentrations of
DMSO, astrocytes on coverslips were washed with PBS and fixed
in freshly made 4% paraformaldehyde for 1 h. After permeabilization with 0.1% Triton X-100 (dissolved in 0.1% sodium citrate)
for 5 min, the coverslips were incubated with 20 mg/ml proteinase
K for 15 min at 37uC, then incubated with 100 ml TUNEL
reaction mixture for 1 h at 37uC. The reaction was ceased by
washing with PBS for 3 times. After counterstaining with Hoechst
33342 (Sigma-Aldrich), TUNEL positive cells were captured using
a Leica DM4000B digital microscope (Leica Microsystems,
Wetzlar, Germany). The percentage of TUNEL positive astrocytes
in the culture was counted.

Isolation of mitochondrial fraction and cytosolic fraction
Each cell sample was homogenized in ice-cold lysis buffer
containing 200 mM mannitol, 80 mM HEPES-KOH (pH 7.4),
and the protease inhibitor cocktail. Homogenates were centrifuged
briefly at 750 rpm for 10 min at 4uC in an Eppendorf centrifuge.
After removing the top half of the supernatants, the rest of the
supernatants were centrifuged at 8,000 rpm for 20 min at 4uC.
The pellets were then washed 3 times and suspended in the lysis
buffer as the mitochondrial fraction. Supernatants of 8,000 rpm
centrifugation were centrifuged at 100,000 rpm for 1 h at 4uC.
The resulting supernatants were cytosolic fraction. The protein
concentration of each sample was determined using the Bradford
assay.

Immunostaining
After washing 3 times in PBS, astrocytes on coverslips, or
dewaxed hippocampal sections, were treated with 2% Triton X100 containing 0.5% bovine serum albumin (BSA) (Sigma-Aldrich)
for 1 h. They were then incubated with mouse monoclonal
antibody against GFAP (1:1000; Sigma-Aldrich), rabbit polyclonal
antibody against GLT-1 (1:400; Santa Cruz) or rabbit polyclonal
antibody against GLAST (1:400, Santa Cruz) at 4uC overnight.
After PBS rinses, appropriate secondary antibodies were applied
for 1 h at 37uC. The signals were visualized by 3,39-diaminobenzidine (DAB) (Sigma-Aldrich) and captured using a Leica
DM4000B digital microscope. The mean integrated optical
density (MIOD) was measured to assess the expression levels of
GFAP, GLT-1 or GLAST using Image J software. The data are
presented as percentage of control values.

Western blot analysis
DMSO-treated astrocytes were washed with Ca2+- and Mg2+free PBS, then detached from the plates by scraping, and
harvested by centrifugation for 5 min at 1500 g. Cell pellets were
suspended in 60 ml lysis buffer containing 200 mM phenylmethylsulfonylfluoride (PMSF) and homogenized on ice by an ultrasonic
homogenizer. The lysates were centrifuged (12,000 rpm for
15 min at 4uC) and the protein concentration in the extracts
was determined using the Bradford assay. Samples of the cell
extracts or mitochondrial and cytosolic fractions were denatured
with a SDS sample buffer and separated by 10% SDS-PAGE.
Proteins were transferred onto PVDF membranes followed by
blocking membranes with 5% skimmed milk dissolved in TBST
(50 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, 0.1%
Tween20) at room temperature for 2 h. After three washes with
TBST buffer, membranes were incubated with mouse monoclonal
anti-Cyt c (1:2000; Abcam), rabbit polyclonal antibody against
procaspase 3 (1:1200; Abcam), rabbit polyclonal antibody against
cleaved-caspase 3 (1:800; Abcam), rabbit polyclonal antibody
against Bcl-2 (1:200; Santa Cruz BioTech, Santa Cruz, CA, USA),
rabbit polyclonal antibody against GLT-1 (1:500; Santa Cruz
BioTech) or rabbit polyclonal antibody against GLAST (1:500,
Santa Cruz BioTech), rabbit polyclonal antibody against COX IV
(1:1200; Abcam) or mouse monoclonal antibody against b-tubulin
(1:3000; Abcam) at 4uC overnight. The bands were detected with
biotin conjugated secondary antibodies (1:200, Vector Laborato-

Statistical analysis
Data are expressed as mean 6 SEM. All statistical analyses were
performed using SPSS software, version 16.0 (SPSS Inc., USA).
The significance of difference was evaluated with one-way analysis
of variance (ANOVA) procedures followed by the Bonferroni test.
P-values less than 0.05 were considered statistically significant.
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